IceCure Medical Ltd (ICCM)
- Previous Close
1.1900 - Open
1.2100 - Bid 1.1500 x 100
- Ask 1.2100 x 400
- Day's Range
1.1820 - 1.2182 - 52 Week Range
0.5200 - 1.5700 - Volume
60,595 - Avg. Volume
702,590 - Market Cap (intraday)
54.876M - Beta (5Y Monthly) 2.97
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.33
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
icecure-medical.comRecent News: ICCM
Performance Overview: ICCM
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ICCM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ICCM
Valuation Measures
Market Cap
54.88M
Enterprise Value
44.41M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
16.96
Price/Book (mrq)
4.51
Enterprise Value/Revenue
13.75
Enterprise Value/EBITDA
-2.91
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-41.78%
Return on Equity (ttm)
-77.97%
Revenue (ttm)
3.23M
Net Income Avi to Common (ttm)
-14.65M
Diluted EPS (ttm)
-0.3200
Balance Sheet and Cash Flow
Total Cash (mrq)
11.06M
Total Debt/Equity (mrq)
4.93%
Levered Free Cash Flow (ttm)
-7.75M